a16z (Andreessen Horowitz): Q3 2026 13F
Silicon Valley venture firm; its 13F shows the public stakes it holds after IPOs.
Holdings as of Sep 30, 2026 (Q3 2026)Filed Nov 16, 202613F deadline Nov 16, 2026 (45 days after quarter end)
Portfolio at a glance
Largest stock and ETF positions sized by weight, coloured by change since the previous 13F.
Biggest moves
Estimated dollars bought and sold in Q3 2026 (change in shares × quarter-end price).
Top buys
Ranked by estimated dollars added: change in shares × quarter-end price.
| Stock | Change | Est. $ |
|---|---|---|
Space Exploration Techn Corp | Added+62.7% | +$7.1B |
BRVE Braveheart Bio Inc | New | +$207M |
FRNM Freenome Inc | New | +$88M |
LIME Neutron Holdings Inc | New | +$80M |
SCTX Scribe Therapeutics Inc | New | +$57M |
STDN Standard Nuclear Inc | New | +$35M |
BLSM Blossomhill Therapeutics Inc | New | +$2M |
Top sales
Ranked by estimated dollars sold, including full exits.
New positions
| Stock | Change | Est. $ |
|---|---|---|
BRVE Braveheart Bio Inc | New | +$207M |
FRNM Freenome Inc | New | +$88M |
LIME Neutron Holdings Inc | New | +$80M |
SCTX Scribe Therapeutics Inc | New | +$57M |
STDN Standard Nuclear Inc | New | +$35M |
BLSM Blossomhill Therapeutics Inc | New | +$2M |
Sold out
| Stock | Change | Est. $ |
|---|---|---|
OMDA Omada Health Inc | Sold out | −$25M |
Largest holdings
Top 24 of 24 stock and ETF positions, as of Sep 30, 2026. Options are listed separately below.
| Stock | Change | Value |
|---|---|---|
Space Exploration Techn Corp | Added+62.7% | $18.4B |
NAVN Navan Inc | Unchanged | $592M |
BRVE Braveheart Bio Inc | New | $207M |
Revolution Medicines Inc | Trimmed-15% | $161M |
FRNM Freenome Inc | New | $88M |
LIME Neutron Holdings Inc | New | $80M |
Block Inc | Unchanged | $75M |
SCTX Scribe Therapeutics Inc | New | $57M |
Figma Inc | Trimmed-57.1% | $54M |
MAZE Maze Therapeutics Inc | Unchanged | $46M |
STDN Standard Nuclear Inc | New | $35M |
DMRA Damora Therapeutics Inc | Unchanged | $26M |
BIOA Bioage Labs Inc | Unchanged | $23M |
ERAS Erasca Inc | Trimmed-50% | $21M |
Meta Platforms Inc | Trimmed-90.1% | $15M |
Roblox Corp | Unchanged | $12M |
CAMP Camp4 Therapeutics Corp | Unchanged | $9M |
AKTS Aktis Oncology Inc | Unchanged | $8M |
BTGO Bitgo Holdings Inc | Unchanged | $5M |
NAUT Nautilus Biotechnology Inc | Trimmed-70.7% | $4M |
BLSM Blossomhill Therapeutics Inc | New | $2M |
KLRA Kailera Therapeutics Inc | Unchanged | $2M |
DNA Ginkgo Bioworks Holdings Inc | Unchanged | $1M |
IPST Ip Strategy Holdings Inc | Unchanged | $13K |
Source: a16z Capital Management, L.L.C., Form 13F-HR on SEC EDGAR, compared with the filing for Jun 30, 2026. 13F shows only US-listed long positions (plus listed options), is delayed up to 45 days, and estimated dollar changes assume the quarter-end price. Not investment advice. How we calculate this.